Position in HIMS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$247,977,102
+$63,439,640 QoQ
Shares Held
7,152,498
-19.5% QoQ
Ownership
3.07%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#5
of 503 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 93%
Shared 0%
None 7%
Common Shares in HIMS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $3,507,444,037 across 76 Drug Manufacturers - Specialty & Generic names. HIMS ranks #2 (7.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
8,878,849 | $638,034,078 | |
| 2 | HIMS |
Hims & Hers Health, Inc.
This page
|
7,152,498 | $247,977,102 | |
| 3 | VTRS |
Viatris Inc
|
15,128,899 | $240,246,911 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
436,699 | $236,616,614 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
6,968,719 | $236,100,195 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
1,318,607 | $222,238,016 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
7,854,362 | $193,295,842 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
1,726,303 | $191,516,050 |
All Filings in HIMS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $247,977,102 | 7,152,498 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $184,537,462 | 8,889,088 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $127,582,159 | 3,929,232 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $412,700,160 | 7,276,096 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $275,621,842 | 5,529,024 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $139,399,107 | 4,717,398 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $97,420,999 | 4,028,991 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $39,084,897 | 2,121,873 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $54,716,047 | 2,710,057 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $42,007,188 | 2,715,397 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $10,878,805 | 1,222,338 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $9,293,351 | 1,477,481 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $24,975,203 | 2,656,937 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $22,539,506 | 2,272,128 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $7,212,797 | 1,125,242 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,167,969 | 209,314 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $968,727 | 213,848 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $3,929,102 | 737,168 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $2,892,407 | 441,589 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $7,888,073 | 1,046,164 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $808,516 | 74,244 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $164,978 | 12,470 | Shares | Defined | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||